Julia Brigden, known as “The Girl,” inspired songs by Jefferson Starship, the Steve Miller Band and others. As a photogenic ...

Not all monthly dividend stocks are created equal. And this top stock is certainly a strong choice for passive income.

Choice Hotels' Q3 performance beat expectations, raising the full-year outlook. Learn why CHH stock remains attractive for ...

The lithium companies will have to create a new royalty rate proposal, another delay for the commercial extraction of the ...

On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

TGI Friday’s Inc. is speaking with potential buyers, a company attorney said Monday, and disclosed it suffered a “significant ...

Dividend stocks are providing passive income for millions of investors who use the funds to help meet monthly budgets stressed from inflation.

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...

Syndax has entered into a synthetic royalty funding agreement with Royalty Pharma, focused on US net sales of Niktimvo.

The lithium companies brought in an army of experts to make the case that their proposed royalty rate is on par with other ...

Detailed price information for Diversified Royalty Corp (DIV-T) from The Globe and Mail including charting and trades.

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax ...